ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 AC&R Study Summaries: Avoidable RA Hospitalizations, Psoriasis to Psoriatic Arthritis Transition, & Neighborhood Conditions in Childhood Lupus

Arthritis Care & Research  |  Issue: September 2025  |  September 8, 2025

Neighborhood Conditions & Childhood Lupus

By Joyce Chang, MD, MSCE

Why was this study done? The environments in which children are born, live, grow and learn influence a wide range of health outcomes. Child opportunity encompasses neighborhood resources and conditions important for healthy childhood development. Differential access to child opportunity may drive disparities in outcomes of childhood-onset systemic lupus erythematosus (cSLE). We examined whether children with cSLE living in areas with lower child opportunity present with more severe disease and are less likely to achieve disease control.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What were the study methods? This was a retrospective study of patients with cSLE cared for at three tertiary care centers between 2016–2022. We linked census tract identifiers to the Child Opportunity Index (COI) version 2.0, a multidimensional, area-level indicator of child opportunity across domains of education, health and environment, and socioeconomic conditions. Mixed effects models were used to estimate associations between COI and primary outcomes of severe disease presentation (high disease activity scores, need for intensive care, or dialysis) and acute care visits during the first year of follow-up, adjusted for age, sex, race and ethnicity, language and insurance status.

What were the key findings? Among 538 patients with cSLE, those living in areas with low child opportunity had 1.9-fold higher adjusted odds of severe disease presentation and twofold higher adjusted incidence of acute care visits, compared to those in areas with very high opportunity. Similarly, patients with cSLE in areas with low opportunity had a substantially lower adjusted odds (OR 0.4) of achieving low disease activity with ≤7.5 mg/day of prednisone, despite adjustment for initial disease severity and disease duration.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What were the main conclusions? Structural inequities in child opportunity may contribute to disparities in disease severity when children with cSLE first present to pediatric rheumatology care, as well as the ability to achieve disease control on lower doses of prednisone, irrespective of initial disease severity.

What are the implications for patients & clinicians? In the care of children with cSLE, it is important to consider the compounded effects of individual family-level factors and local resources or neighborhood conditions. Improving access to timely pediatric rheumatology care for children with cSLE may require tailoring interventions to communities with low levels of child opportunity.

The Study: Chang JC, Liu JP, Smitherman EA, et al. Multicenter study of associations between area-level child opportunity, initial disease severity, and outcomes among children with lupus. Arthritis Care Res (Hoboken). 2025 Aug;77(8):965–974.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsPsoriatic ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RBiomarkersC-reactive proteinCardiovascular diseasechildhood-onset SLEcomorbiditiesDisparitieshospitalizedPediatric RheumatologyPsA Resource CenterPsoriasisRA Resource CenterReading RheumSLE Resource Centersocioeconomic

Related Articles

    Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

    January 1, 2014

    Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Top Research in Psoriatic Arthritis Presented at ACR Convergence 2024

    November 26, 2024

    Editor’s note: What research on psoriatic arthritis (PsA) presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future research? That’s the question The Rheumatologist asked David S. Pisetsky, MD, PhD—our founding editor—to consider. Dr. Pisetsky, a professor of medicine and immunology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences